The application of novel HBV pgRNA assay to predict HBeAg clearance on long-term nucleos (t)ide analogues

被引：2
|
作者：
Shah, Pir Ahmad [1 ]
Rajab, Idriss [1 ]
Choudhry, Saad [1 ]
Gersch, Jeffrey [2 ]
Malladi, Vijayram [1 ]
Ishtiaq, Rizwan [1 ]
Kuhns, Mary [2 ]
Cloherty, Gavin [2 ]
Lau, Daryl [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Gastroenterol Med, Boston, MA 02215 USA
[2] Abbott, Infect Dis Res, Chicago, IL USA
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30495-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-222
引用
收藏
页码：E262 / E263
页数：2
相关论文
共 50 条
  • [41] Prospective, Randomized Assessment of HBV-Associated and Other Clinical Outcome Events During Long-Term Therapy With Entecavir or Other HBV Nucleos(t)ide Analogues in Patients With Chronic HBV Infection
    Hou, Jinlin
    Zhao, Wei
    Lee, Changhyeong
    Hann, Hie-Won
    Peng, Cheng-Yuan
    Tanwandee, Tawesak
    Morozov, Viacheslav
    Berg, Christoph P.
    Sollano, Jose D.
    Cercel, Adrian Streinu
    Cheinquer, Hugo
    Thiry, Alexandra
    Cooney, Elizabeth L.
    Lim, Seng Gee
    HEPATOLOGY, 2017, 66 : 12A - 13A
  • [42] Discontinuation of long-term Nucleos(t)ide analogue therapy before HBsAg loss in HBeAg negative CHB patients: follow-up of long-term responders
    Petersen, Joerg
    Hansen, Bettina E.
    Buggisch, Peter
    Hinrichsen, Holger
    Berg, Thomas
    Wedemeyer, Heiner
    Stoehr, Albrecht
    Chan, Henry Lik-Yuen
    Arends, Pauline
    Wiegand, Steffen B.
    Brunetto, Maurizia R.
    Cornberg, Markus
    Janssen, Harry L.
    HEPATOLOGY, 2013, 58 : 680A - 681A
  • [43] Response to discontinuation of long-term nucleos(t)ide analogue treatment in HBeAg negative patients: Results of the Stop-NUC trial
    van Boemmel, Florian
    Stein, Kerstin
    Heyne, Renate
    Moeller, Hjoerdis
    Petersen, Joerg
    Buggisch, Peter
    Berg, Christoph
    Werner, Christoph
    Zeuzem, Stefan
    Herrmann, Andreas
    Reuken, Philipp
    Sprinzl, Martin
    Grambihler, Annette
    Schott, Eckart
    Benckert, Julia
    Pathil, Anita
    von Arnim, Ulrike
    Keitel, Verena
    Trauth, Janina
    Georg, Simon Karl
    Trautwein, Christian
    Trein, Andreas
    Hueppe, Dietrich
    Cornberg, Markus
    Lammert, Frank
    Ingiliz, Patrick
    Zachoval, Reinhart
    Hinrichsen, Holger
    Zipprich, Alexander
    Klinker, Hartwig
    Zur Wiesch, Julian Schulze
    Brosteanu, Oana
    Schmiedeknecht, Anett
    Berg, Thomas
    JOURNAL OF HEPATOLOGY, 2020, 73 : S118 - S119
  • [44] Long-term outcome of patients with HBeAg-negative chronic hepatitis B (CHBe-) under nucleos(T)ide analogues maintenance therapy starting with lamivudine (LAM)
    Papatheodoridis, GV
    Dimou, E
    Dimakopoulos, K
    Manolakopoulos, S
    Rapti, I
    Tzourmakliotis, D
    Kitis, G
    Manesis, EK
    Hadziyannis, SJ
    HEPATOLOGY, 2004, 40 (04) : 662A - 663A
  • [45] QUANTIFICATION OF HBSAG (HBSAG-Q) IN HBEAG-NEGATIVE PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUES TO PREDICT THE LOSS OF HBSAG
    Broquetas, T.
    Garcia-Retortillo, M.
    Hernandez, J. J.
    Puigvehi, M.
    Fernandez, R.
    Canete, N.
    Coll, S.
    Cabrero, B.
    Gimenez, M. D.
    Bory, F.
    Sola, R.
    Carrion, J. A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S379 - S379
  • [46] On-treatment HBsAg kinetics can predict HBsAg loss after nucleos (t)ide analogues interruption in HBeAg negative patients
    Broquetas, Teresa
    Hernandez, Juan-Jose
    Garcia-Retortillo, Montserrat
    Canillas, Lidia
    Puigvehi, Marc
    Canete Hidalgo, Nuria
    Coll, Susana
    Viu, Ana
    Garrido, Esther
    Romero, Judit
    Bessa, Xavier
    Carrion, Jose A.
    JOURNAL OF HEPATOLOGY, 2021, 75 : S734 - S734
  • [47] Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues
    Ding, Yang
    Dou, Xiaoguang
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 881 - 882
  • [48] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES AND LONG-TERM VIROLOGICAL SUPPRESSION
    Fasano, M.
    Montrano, L.
    Ciarallo, M.
    Caccianotti, B.
    Giammario, A.
    Gioacchino, A.
    Santantonio, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S335 - S335
  • [49] RISK FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA OCCURRENCE IN CHRONIC HEPATITIS B PATIENTS ON LONG-TERM NUCLEOS(T) IDE ANALOGUES
    Murai, Kazuhiro
    Hikita, Hayato
    Yamada, Ryoko
    Miyake, Takayuki
    Sometani, Emi
    Kuriki, Shinji
    Sung, Jihyun
    Shimoda, Akiyoshi
    Shigeno, Satoshi
    Tahata, Yuki
    Saito, Yoshinobu
    Kodama, Takahiro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2024, 80 : S182 - S182
  • [50] Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
    Martin-Carbonero, Luz
    Teixeira, Tiago
    Poveda, Eva
    Plaza, Zulema
    Vispo, Eugenia
    Gonzalez-Lahoz, Juan
    Soriano, Vincent
    AIDS, 2011, 25 (01) : 73 - 79
12345